Home > Insider Trading > Inmune Bio Inc.

Inmune Bio Inc. (INMB)

Market is closed

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

News

First
<< Previous
11 - 15

INmune Bio, Inc. (NASDAQ:INMB) Q1 2023 Earnings Call Transcript

Operator: Good day and welcome to the INmune Bio First Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. Please note today's event is being recorded.

Keep Reading →

May 4th, 2023 - News Transcripts

INmune Bio, Inc. (NASDAQ:INMB) Q4 2022 Earnings Call Transcript

Operator: Greetings, and welcome to the INmune Bio Fourth Quarter and Full Year 2022 Earnings Call. This conference will be recorded.

Keep Reading →

March 6th, 2023 - News Transcripts

10 Best Micro-Cap Stocks to Invest In

As the economy comes back to normal, investors are beginning to pay attention to small companies that are operating in high-growth sectors.

Keep Reading →

September 23rd, 2021 - Hedge Funds News

Where Do Hedge Funds Stand On Inmune Bio Inc. (INMB)?

As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.

Keep Reading →

June 13th, 2021 - Hedge Funds News

Do Hedge Funds Love Inmune Bio Inc. (INMB)?

Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...

Keep Reading →

November 27th, 2020 - Hedge Funds News